rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2001-2-26
|
pubmed:abstractText |
To assess the safety and tolerability of bolus intravenous doses of colistin during acute respiratory exacerbations in adults with cystic fibrosis and chronic Pseudomonas aeruginosa infection.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1060-0280
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1238-42
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11098334-Adult,
pubmed-meshheading:11098334-Anti-Bacterial Agents,
pubmed-meshheading:11098334-Colistin,
pubmed-meshheading:11098334-Cystic Fibrosis,
pubmed-meshheading:11098334-Drug Administration Schedule,
pubmed-meshheading:11098334-Female,
pubmed-meshheading:11098334-Humans,
pubmed-meshheading:11098334-Infusions, Intravenous,
pubmed-meshheading:11098334-Injections, Intravenous,
pubmed-meshheading:11098334-Male,
pubmed-meshheading:11098334-Pseudomonas Infections,
pubmed-meshheading:11098334-Pseudomonas aeruginosa,
pubmed-meshheading:11098334-Respiratory Tract Infections
|
pubmed:year |
2000
|
pubmed:articleTitle |
Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.
|
pubmed:affiliation |
CF Services, St. James's University Hospital, Leeds, England. steven.conway@gw.sjsuh.northy.nhs.uk
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase I
|